Co-administration of the JAK inhibitor CP-690,550 and...

British Journal of Clinical Pharmacology 2010 Vol. 69; Iss. 2

Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment

Stanley Cohen, Samuel H. Zwillich, Vincent Chow, Robert R. LaBadie, Bethanie Wilkinson
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Year:
2010
Language:
english
Pages:
9
DOI:
10.1111/j.1365-2125.2009.03570.x
File:
PDF, 724 KB
english, 2010
Conversion to is in progress
Conversion to is failed